These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16301530)

  • 1. Transgenic rice for allergy immunotherapy.
    Ma S; Jevnikar AM
    Proc Natl Acad Sci U S A; 2005 Nov; 102(48):17255-6. PubMed ID: 16301530
    [No Abstract]   [Full Text] [Related]  

  • 2. Transgenic rice accumulating modified cedar pollen allergen Cry j 2 derivatives.
    Suzuki K; Yang L; Takaiwa F
    J Biosci Bioeng; 2012 Feb; 113(2):249-51. PubMed ID: 22055918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 26-Week oral safety study in macaques for transgenic rice containing major human T-cell epitope peptides from Japanese cedar pollen allergens.
    Domon E; Takagi H; Hirose S; Sugita K; Kasahara S; Ebinuma H; Takaiwa F
    J Agric Food Chem; 2009 Jun; 57(12):5633-8. PubMed ID: 19462978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical safety evaluation of transgenic rice seeds expressing T cell epitopes of Japanese cedar pollen allergens.
    Takagi H; Hirose S; Yasuda H; Takaiwa F
    J Agric Food Chem; 2006 Dec; 54(26):9901-5. PubMed ID: 17177518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of transgenic rice seed accumulating a major Japanese cedar pollen allergen (Cry j 1) structurally disrupted for oral immunotherapy.
    Yang L; Suzuki K; Hirose S; Wakasa Y; Takaiwa F
    Plant Biotechnol J; 2007 Nov; 5(6):815-26. PubMed ID: 17714439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of transgenic rice lines with reduced contents of multiple potential allergens using a null mutant in combination with an RNA silencing method.
    Wakasa Y; Hirano K; Urisu A; Matsuda T; Takaiwa F
    Plant Cell Physiol; 2011 Dec; 52(12):2190-9. PubMed ID: 22039121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the use of transgenic rice seeds in oral immunotherapy.
    Takaiwa F
    Immunotherapy; 2013 Mar; 5(3):301-12. PubMed ID: 23444957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with transgenic rice seed expressing mite allergen: a new option for asthma sufferers?
    Hiroi T; Kaminuma O; Takaiwa F
    Expert Rev Vaccines; 2011 Sep; 10(9):1249-51. PubMed ID: 21919612
    [No Abstract]   [Full Text] [Related]  

  • 9. Proteomic analysis of known and candidate rice allergens between non-transgenic and transgenic plants.
    Satoh R; Nakamura R; Komatsu A; Oshima M; Teshima R
    Regul Toxicol Pharmacol; 2011 Apr; 59(3):437-44. PubMed ID: 21300107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation by double-blind placebo-controlled oral challenge of the clinical relevance of IgE antibodies against plant glycans.
    Mari A; Ooievaar-de Heer P; Scala E; Giani M; Pirrotta L; Zuidmeer L; Bethell D; van Ree R
    Allergy; 2008 Jul; 63(7):891-6. PubMed ID: 18588555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rice seed ER-derived protein body as an efficient delivery vehicle for oral tolerogenic peptides.
    Takagi H; Hiroi T; Hirose S; Yang L; Takaiwa F
    Peptides; 2010 Aug; 31(8):1421-5. PubMed ID: 20457197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of allergen-induced airway inflammation by low-dose oral immunotherapy with transgenic rice seeds independently of immunoglobulin e synthesis.
    Saeki M; Nishimura T; Kaminuma O; Suzuki K; Takai T; Mori A; Takada K; Takaiwa F; Hiroi T
    Int Arch Allergy Immunol; 2012; 158 Suppl 1():66-9. PubMed ID: 22627369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide immunotherapy for allergic diseases using a rice-based edible vaccine.
    Hiroi T; Takaiwa F
    Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):455-60. PubMed ID: 17088651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monitoring specific immunotherapy using the 3M Diagnostic Systems reagent kits].
    Szymański W; Chyrek-Borowska S
    Pneumonol Alergol Pol; 1991; 59 Suppl 1():23-30. PubMed ID: 1843805
    [No Abstract]   [Full Text] [Related]  

  • 15. What will allergen immunotherapy look like in the future?
    Nelson HS
    Ann Allergy Asthma Immunol; 2012 Aug; 109(2):87-9. PubMed ID: 22840246
    [No Abstract]   [Full Text] [Related]  

  • 16. Date palm pollen allergoid: characterization of its chemical-physical and immunological properties.
    Mistrello G; Harfi H; Roncarolo D; Kwaasi A; Zanoni D; Falagiani P; Panzani R
    Int Arch Allergy Immunol; 2008; 145(3):224-30. PubMed ID: 17914274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant pollen allergens from Dactylis glomerata: preliminary evidence that human IgE cross-reactivity between Dac g II and Lol p I/II is increased following grass pollen immunotherapy.
    Roberts AM; Van Ree R; Cardy SM; Bevan LJ; Walker MR
    Immunology; 1992 Jul; 76(3):389-96. PubMed ID: 1526648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of Rice Seed-Based Allergy Vaccines.
    Takagi H; Takaiwa F
    Methods Mol Biol; 2016; 1403():713-21. PubMed ID: 27076162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of the allergen, Pru p 1 in adult patients with birch pollen-associated oral allergy syndrome.
    Hwang EK; Kim JH; Nam YH; Jin HJ; Park HS
    Allergy; 2011 Dec; 66(12):1621-2. PubMed ID: 21981242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.